Aptus Pharma Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 880,000 (47%) | — | ₹616 Cr |
| NII (HNI) | — | 266,000 (14%) | — | ₹186 Cr |
| Retail | — | 620,000 (33%) | — | ₹434 Cr |
| Market Maker | — | 94,000 (5%) | — | ₹7 Cr |
| Σ Total | — | 1,860,000 (100%) | — | ₹13,020 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 2,000 | ₹140,000 |
| Retail (Max) | 13 | 26,000 | ₹1,820,000 |
| S-HNI (Min) | 14 | 28,000 | ₹1,960,000 |
| B-HNI (Min) | 67 | 134,000 | ₹9,380,000 |
Financial Statements Amount in ₹ Crore
| Metric | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 25 | 18 | 14 |
| EBITDA | 5 | 1 | 1 |
| Profit After Tax | 3 | 1 | 0 |
| Net Worth | 7 | 2 | 1 |
| Total Assets | 22 | 10 | 6 |
| Reserves & Surplus | 2 | 1 | 1 |
| Total Borrowing | 10 | 5 | 2 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Capital Expenditure for Office Premises with furniture and Industrial Racks – 1.63
- Working Capital – 8
- General corporate purposes –
Company Overview
Incorporated in 2010, Aptus Pharma Ltd is engaged in the business of marketing, and distribution of finished pharmaceutical formulations
The company manufactures and distributors of a broad range of pharmaceutical formulations covering multiple therapeutic areas: antacids & PPIs, pain management, anti-inflammatories, antibiotics, cardiology & antidiabetics, neuropsychiatry, dental, injectable parenterals, syrups, nutraceuticals, sachets, and more.
Products:
- Aptus Pharma: Focuses on acute therapies i.e, anti-infectives, pain management, etc.
- Aptus CD care: Focused on chronic therapies
- Aptus Wellcare: Offers wellness and nutraceutical products
- Aptus Global: Export in overseas market
As of March 31, 2025, the company has 194 pharmaceutical formulations in more than eleven therapeutic segments.
Its warehouse is located over 15,732 sq. Feet and 1989 sq. feet in Ahmedabad, Gujarat. Its distribution model includes 125 direct and sub distributors and a sales team of 54 field personnel.
As of March 31, 2025, the company had 70 employees.
Competitive Strengths
- Diversified product portfolio
- Robust distribution network
- Strategic manufacturing alliances across Gujarat, Uttarakhand and Himachal Pradesh
- Competitive and cost-effective pricing
- Experienced management team